Global Hepatitis Burden – Data for Action on Access of a Leading Infectious Disease Burden
Fuqiang Cui(Peking University), Daniel Low‐Beer(World Health Organization), Shevanthi Nayagam(Imperial College London), Peter Vickerman(At Bristol), Mónica Alonso González(Consumer Healthcare Products Association), Polin Chan(Western University), Casimir Manzengo Mingiedi(World Health Organization Regional Office for Africa), Timothy B. Hallett(Imperial College London), Devin Razavi‐Shearer(University of Health Sciences Antigua), Homie Razavi(Center for Disease Analysis), Niklas Luhmann(World Health Organization - Pakistan), Olufunmilayo Lesi(University of Lagos), Catherine de Martel(Centre international de recherche sur le cancer), Ahmed Sabry Alaama(World Health Organization Regional Office for the Eastern Mediterranean), Antons Mozalevskis(World Health Organization), Meg Doherty(World Health Organization), M. Ashworth Dirac(Institute for Health Metrics and Evaluation), Diana Faini(Ifakara Health Institute), Mohamed Amine Ghrabi, Kiyohiko Izumi(World Health Organization Regional Office for the Western Pacific)
Cited by 0
Related Papers
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Global burden of primary liver cancer in 2020 and predictions to 2040
|Journal of Hepatology|2022|2.1k
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k
Global, regional and national burden of primary liver cancer by subtype
|European Journal of Cancer|2021|581